• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Consumer Discretionary

The Price Is Wrong -- but Buy Sally Beauty and Francesca's Anyway

Neither company is currently respected, or getting credit for its progress, in the market.
By PAUL PRICE
Oct 29, 2017 | 12:00 PM EDT
Stocks quotes in this article: SBH, FRAN

There are many ways to make money in the market. One of my favorites is simply to play with shares that appear clearly mispriced vs. their corporate fundamentals.

How can you know that is the case?

Compare easily verifiable metrics with the stock's price performance over time. When shares have lagged the actual value created, there is often opportunity. The more disparate the valuations, the greater the potential gain.

Two that jump out at me in this category are Sally Beauty Holdings (SBH) and Francesca's (FRAN) . Both have clearly made tons of measurable progress over the years. Neither is currently respected, or getting credit for that, in the market.

Since 2010, SBH has almost doubled its sales per share. Cash flow and earnings did even better, rising 157% and 133%, respectively.

Sally's share price, however, is up only 39.2% from the same date in 2010.

There are no obvious problems with operations. In fact, fiscal 2017 (ended Sept. 30) is expected to have set all-time records when fourth-quarter and full-year results are released in early November.

Since 2012, there were four chances to sell SBH at prices from $31 to $35. In two other recent years, SBH peaked at $27 to $28. A simple return to those levels would provide large-percentage gains from Wednesday's quote of $17.47.

All SBH needs to reach $30 to $35 within 12 to 18 months is a regression to the mean valuation. Insiders, including the firm's CEO, have been heavy buyers. No insiders have sold in recent months.

SBH's trailing P/E last Wednesday is tied for its lowest since the dark days of 2008-09.

I've been accumulating shares and selling puts on weakness. Sally's June 15, 2018, puts offer nice premiums along with reasonable margins of safety. SBH hasn't actually changed hands for as little as $16.50 since 2011.

Francesca's offers a similar, high-potential upside, relatively low-risk profile for value-oriented investors. FRAN has a history of scary selloffs followed by equally sharp, tradable rebounds.

The company's fundamentals belie the extraordinary price movements. EPS growth has been spottier than Sally Beauty's, but FRAN has always remained profitable. Revenues and cash flow are up dramatically since the company's 2011 IPO. Profits are higher this year than in 2011, even during a relatively poor year.

The stock, rationally worth way more than six years ago, is down about 72% from its Oct. 25, 2011, quote. That's what I call a truly mispriced stock.

Analysts think this year's earnings disappointment will be temporary. Value Line expects FRAN to show EPS of about $1.75 no later than 2022.

The stock has never been offered with a more reasonable multiple. A partial pick up to a still-below-average, for FRAN, P/E of 16x could easily support a 12- to 15-month goal price of $12.80.

That's a cool 89% above Wednesday's asking price.

Option sellers can get paid generous premiums for committing to stand ready to own FRAN even cheaper. Worst-case, forced-purchase prices on the June 15, 2018, expiration date $7 and $8 strikes drop the "if exercised" net entry cost to either $5.60 or $6.05.

Future stock market action can never be guaranteed. We can know for sure, though, that either break-even point falls below FRAN all-time lows. This debt-free, money-making company is not in danger of disappearing.

A return to its early 2017 level would represent a 188% profit for those brave enough to buy now, when others are fleeing the shares.

Deciding between Sally and Fran proved too tough a choice for me. I'm going out with both girls and hoping to get lucky.

Buy both stocks, sell some puts or consider doing some of each.

The following article originally appeared Oct. 26 on Real Money Pro, our dynamic site for active traders. Click here to get great columns like this from Paul Price five days a week.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Price was long shares of SBH and FRAN, short puts on SBH and FRAN, although positions may change at any time.

TAGS: Investing | U.S. Equity | Consumer Discretionary | How-to | Options | Stocks

More from Consumer Discretionary

Apple's Price Charts Are Getting Badly Bruised

Bruce Kamich
May 12, 2022 1:10 PM EDT

Here's what the odds favor.

RH and Its Charts Don't Have That Homey Feeling Right Now

Bruce Kamich
May 12, 2022 8:32 AM EDT

The technical signals of the home furnishings provider indicate more downside to come in its stock.

Crocs Is Still Slipping to the Downside on Its Charts

Bruce Kamich
May 11, 2022 7:44 AM EDT

The footwear maker isn't seeing a lot of technical support at this point.

Screening for Deep-Value Stocks Turns Up a Pair of Possibilities

Jonathan Heller
May 9, 2022 10:00 AM EDT

A producer of small appliances and a maker of fishing, camping and kayaking gear pop up as possible value plays.

Bearish Bets: 3 Slumping Stocks You Should Consider Shorting This Week

Bob Lang
May 8, 2022 10:30 AM EDT

These recently downgraded names are displaying both quantitative and technical deterioration.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:24 PM EDT PAUL PRICE

    An interesting chart

    I'm betting heavily that stocks will be way up aga...
  • 10:10 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "Market Timing for Dummies"
  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login